CELLECTIS
Summary
Cellectis is a clinical-stage biopharmaceutical company developing the Next-Generation CAR T-Cells to Cure Cancer.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 202 M
Avg. Deal Size£ 202 M
All rights reserved. Copyright © 2025 Datasite
